Merck kündigt die skalierbare biokatalytische Synthese des experimentellen oralen PCSK9-Inhibitors Enlicitide Decanoate an.

Quelle: Merck.com
Link: https://www.merck.com/news/merck-scientists-publish-landmark-paper-on-novel-method-for-large-scale-biocatalytic-synthesis-of-investigational-oral-pcsk9-inhibitor-enlicitide-decanoate/